Adicet Bio, Inc.
ACET
$9.64
-$0.09-0.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -5.68% | -40.39% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.39% | -32.35% | |||
| Operating Income | -3.39% | 32.35% | |||
| Income Before Tax | -4.80% | 33.66% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -5.50% | 33.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.50% | 33.66% | |||
| EBIT | -3.39% | 32.35% | |||
| EBITDA | -4.32% | 33.49% | |||
| EPS Basic | -5.49% | 35.99% | |||
| Normalized Basic EPS | -4.78% | 35.99% | |||
| EPS Diluted | -5.49% | 35.99% | |||
| Normalized Diluted EPS | -4.78% | 35.99% | |||
| Average Basic Shares Outstanding | 0.01% | 3.64% | |||
| Average Diluted Shares Outstanding | 0.01% | 3.64% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||